Literature DB >> 16227367

Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma.

R McWilliams, W E Highsmith, K G Rabe, M de Andrade, L A Tordsen, L M Holtegaard, G M Petersen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16227367      PMCID： PMC1774726          DOI： 10.1136/gut.2005.074534

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

1.  Pancreatic adenocarcinoma in a patient with cystic fibrosis.

Authors:  J C McIntosh; R A Schoumacher; R E Tiller
Journal:  Am J Med       Date:  1988-10       Impact factor: 4.965

2.  Adenocarcinoma in cystic fibrosis.

Authors:  T M Davis; E H Sawicka
Journal:  Thorax       Date:  1985-03       Impact factor: 9.139

3.  Risk factors for pancreatic cancer: a case-control study based on direct interviews.

Authors:  D T Silverman
Journal:  Teratog Carcinog Mutagen       Date:  2001

4.  Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group.

Authors:  N Malats; T Casals; M Porta; L Guarner; X Estivill; F X Real
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

5.  Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer.

Authors:  Hiroyuki Matsubayashi; Noriyoshi Fukushima; Norihiro Sato; Kieran Brune; Marcia Canto; Charles J Yeo; Ralph H Hruban; Scott E Kern; Michael Goggins
Journal:  Cancer Biol Ther       Date:  2003 Nov-Dec       Impact factor: 4.742

6.  Mutations of the cystic fibrosis gene in patients with chronic pancreatitis.

Authors:  N Sharer; M Schwarz; G Malone; A Howarth; J Painter; M Super; J Braganza
Journal:  N Engl J Med       Date:  1998-09-03       Impact factor: 91.245

7.  Prior history of allergies and pancreatic cancer in the San Francisco Bay area.

Authors:  Elizabeth A Holly; Carey A Eberle; Paige M Bracci
Journal:  Am J Epidemiol       Date:  2003-09-01       Impact factor: 4.897

8.  Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.

Authors:  A B Lowenfels; P Maisonneuve; G Cavallini; R W Ammann; P G Lankisch; J R Andersen; E P Dimagno; A Andrén-Sandberg; L Domellöf
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

9.  The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group.

Authors:  J P Neglia; S C FitzSimmons; P Maisonneuve; M H Schöni; F Schöni-Affolter; M Corey; A B Lowenfels
Journal:  N Engl J Med       Date:  1995-02-23       Impact factor: 91.245

10.  A cohort study of cystic fibrosis and malignancy.

Authors:  C D Sheldon; M E Hodson; L M Carpenter; A J Swerdlow
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640
  10 in total
  26 in total

1.  Genetic susceptibility to pancreatic cancer.

Authors:  Alison P Klein
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

Review 2.  Biology and management of pancreatic cancer.

Authors:  Paula Ghaneh; Eithne Costello; John P Neoptolemos
Journal:  Gut       Date:  2007-08       Impact factor: 23.059

3.  Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma.

Authors:  Robert R McWilliams; Gloria M Petersen; Kari G Rabe; Leonard M Holtegaard; Pamela J Lynch; Michele D Bishop; W Edward Highsmith
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

4.  CFTR is a tumor suppressor gene in murine and human intestinal cancer.

Authors:  B L N Than; J F Linnekamp; T K Starr; D A Largaespada; A Rod; Y Zhang; V Bruner; J Abrahante; A Schumann; T Luczak; A Niemczyk; M G O'Sullivan; J P Medema; R J A Fijneman; G A Meijer; E Van den Broek; C A Hodges; P M Scott; L Vermeulen; R T Cormier
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

5.  Inhibition of acinar apoptosis occurs during acute pancreatitis in the human homologue DeltaF508 cystic fibrosis mouse.

Authors:  Matthew J DiMagno; Sae-Hong Lee; Chung Owyang; Shi-yi Zhou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-03       Impact factor: 4.052

Review 6.  Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.

Authors:  Shiro Urayama
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

7.  Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk.

Authors:  Yafei Li; Zhifu Sun; Yanhong Wu; Dusica Babovic-Vuksanovic; Yan Li; Julie M Cunningham; Vernon S Pankratz; Ping Yang
Journal:  Lung Cancer       Date:  2010-02-08       Impact factor: 5.705

8.  Screening for pancreatic cancer: current evidence and future directions.

Authors:  Julia B Greer; Randall E Brand
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-12

Review 9.  Subject review: pancreatic ductal adenocarcinoma in the setting of mutations in the cystic fibrosis transmembrane conductance regulator gene: case report and review of the literature.

Authors:  David W Rittenhouse; Vanessa A Talbott; Zafia Anklesaria; Jonathan R Brody; Agneszkia K Witkiewicz; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2011-08-02       Impact factor: 3.452

10.  Identification of a novel kindred with familial pancreatitis and pancreatic cancer.

Authors:  Jennifer LaFemina; Penelope A Roberts; Yin P Hung; James F Gusella; Dushyant Sahani; Carlos Fernández-del Castillo; Andrew L Warshaw; Sarah P Thayer
Journal:  Pancreatology       Date:  2009-04-29       Impact factor: 3.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.